Celebrating a Milestone: Our Experience at the World Diabetes Week with IMA Dignitaries and All India Federation of Tax Practitioners (AIFTP)
In the spirit of World Diabetes Week, we recently had the unique opportunity to showcase our innovative work in diabetic retinopathy screening to prominent members of the Indian Medical Association (IMA) and the All India Federation of Tax Practitioners (AIFTP). This gathering marked a significant milestone for our team, as we received widespread acclaim from leaders in both the medical and legal fields.
Dr. Sharad Agarwal, President of the National IMA, and Dr. Vani Puri, President of IMA Ghaziabad, led the roster of esteemed medical professionals who lauded our efforts. Their recognition went beyond mere honor; it served as a powerful validation of the crucial role diabetic retinopathy screening plays in public health.
National IMA President Dr. Sharad Agarwal, IMA president Ghaziabad Dr. Vani Puri, Secretary IMA, and other dignitaries from IMA.
Dr. Agarwal, in particular, was deeply interested in the technology and functioning of our digitalized mobile retina clinic. His insightful queries and understanding of the field’s intricacies were truly inspiring. He highlighted the pivotal role such technological advancements play in extending healthcare services to under-served communities.
Dr. Vani Puri, together with the Secretary of IMA Ghaziabad and several senior IMA members, also expressed their profound appreciation for our work. Their encouraging words emphasized the need for a united effort in the healthcare sector to combat diabetes and its associated complications.
Additionally, the event was graced by distinguished members of AIFTP. Former President and Secretary General of AIFTP, Mr. Mukul Gupta, along with Mr. J.R. Jain, Secretary of the North Zone, and the Treasurer of AIFTP North Zone, were present. Their presence and congratulatory messages added a unique dimension to the event, bridging the gap between healthcare and legal professionals in addressing public health challenges.
Our team was ecstatic to receive such high-level endorsements from both the medical and legal fraternities. This recognition was not just an acknowledgment of our present endeavors but also a significant motivator for our future projects. The event offered us a moment to reflect on our journey, the hurdles we’ve surmounted, and the impact we’ve created in diabetic healthcare.
As we forge ahead in our mission to enhance diabetic eye care, the support and encouragement from leaders of IMA and AIFTP reinforce our commitment. It’s a reminder that our work contributes not only to individual health but also plays a critical role in the wider narrative of healthcare and public welfare.
In summary, the World Diabetes Week event was a landmark experience. It provided us with a priceless opportunity to engage with leading professionals in healthcare and law, offering insights into the future of diabetic care. We are immensely grateful for the recognition and support from both the IMA and AIFTP communities and are more motivated than ever to continue our fight against diabetic retinopathy.
Together, with renewed energy and determination, we aim to make a meaningful difference in the lives of those affected by diabetes.
